MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
0.8951
+0.0719
+8.73%
Closed 19:16 11/06 EST
OPEN
0.8500
PREV CLOSE
0.8232
HIGH
0.9150
LOW
0.8400
VOLUME
1.11M
TURNOVER
0
52 WEEK HIGH
1.930
52 WEEK LOW
0.7882
MARKET CAP
261.94M
P/E (TTM)
-1.6554
1D
5D
1M
3M
1Y
5Y
1D
MaxCyte, Inc. (MXCT) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 11h ago
Weekly Report: what happened at PGEN last week (1028-1101)?
Weekly Report · 3d ago
Weekly Report: what happened at PGEN last week (1021-1025)?
Weekly Report · 10/28 09:23
Weekly Report: what happened at PGEN last week (1014-1018)?
Weekly Report · 10/21 09:23
Weekly Report: what happened at PGEN last week (1007-1011)?
Weekly Report · 10/14 09:27
Patient Capital Management Q3 2024 Investment Review
Seeking Alpha · 10/11 12:00
Precigen Terminates License Agreement With Alaunos Therapeutics
Dow Jones · 10/10 22:31
Precigen Regains Full Control of Technology Post Agreement Termination
TipRanks · 10/10 20:59
More
About PGEN
Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.